Importance of the ROMA Test
- Helps differentiate between benign and malignant ovarian masses.
- Provides an accurate risk assessment prior to surgical intervention.
- Offers higher sensitivity than using CA-125 testing alone.
Book ROMA Index Test in Saudi Arabia | Lahalak Medical Platform
A sophisticated screening tool combining HE4 and CA-125 levels to calculate the risk of ovarian malignancy. It provides critical insights for surgical planning and early detection in pre and postmenopausal women.
Scientific name: Risk of Ovarian Malignancy Algorithm (ROMA) Test
A clinical algorithm measuring HE4 and CA-125 levels alongside menopausal status to estimate the likelihood of malignancy in women with pelvic masses, aiding in preoperative risk assessment and management.
Service type
Laboratory test
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- HE4 protein level measurement
- CA-125 antigen level measurement
- ROMA Score calculation
Medical Service Information
Target Groups
- Women diagnosed with a pelvic or adnexal mass.
- Patients scheduled for surgery to remove an ovarian tumor.
- Women with a strong family history of ovarian or breast cancer.
Understanding Your Results
- Results are categorized into high or low risk based on a calculated percentage.
- Reference ranges differ significantly between premenopausal and postmenopausal women.
- The score should be interpreted by a gynecologic oncologist or specialist.
Conditions & Notices
- Menopausal status (pre or postmenopausal) must be specified for accurate scoring
Medical services you might also like
